Lead In Treatment with PEG Interferon and Ribavirin is Useful before Initiating Telaprevir in Liver Transplant Recipients with Recurrent Hepatitis C

被引：0
|
作者：
Nair, Satheesh [1 ,2 ]
Satapathy, Sanjaya [1 ,2 ]
Waters, Bradford [1 ,2 ]
机构：
[1] Univ Tennessee, Ctr Hlth Sci, Transplant Inst, Methodist Transplant Inst, Memphis, TN 38163 USA
[2] Vet Affairs Hosp, Memphis, TN USA
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1755
引用
收藏
页码：1052A / 1052A
页数：1
相关论文
共 50 条
  • [41] Mechanism of action of ribavirin in treatment of recurrent hepatitis C after liver transplant
    Ouadri, R
    Giostra, E
    Rubbia-Brandt, L
    Mentha, G
    Malè, PJ
    Hadengue, A
    Negro, F
    JOURNAL OF HEPATOLOGY, 2000, 32 : 91 - 91
  • [42] Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C
    Lena Sibulesky
    Justin H Nguyen
    Ricardo Paz-Fumagalli
    C Burcin Taner
    Rolland C Dickson
    World Journal of Gastroenterology, 2009, 15 (40) : 5010 - 5013
  • [43] Preliminary treatment results of pegylated interferon alpha 2b and ribavirin in liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2b and ribavirin
    Neff, GW
    Montalbano, M
    Ozden, N
    Muslu, H
    Lee, YM
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Madariaga, J
    Levi, D
    Nashida, S
    Kato, T
    Schiff, E
    Tzakis, A
    JOURNAL OF HEPATOLOGY, 2003, 38 : 160 - 160
  • [44] Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C
    Sibulesky, Lena
    Nguyen, Justin H.
    Paz-Fumagalli, Ricardo
    Taner, C. Burcin
    Dickson, Rolland C.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (40) : 5010 - 5013
  • [45] Sofosbuvir and Simeprevir in the Treatment of Recurrent Hepatitis C in Liver Transplant Recipients
    Greenberg, Adam
    Saab, Sammy
    Li, Edwin
    Bau, Sherona
    TRANSPLANTATION, 2015, 99 : 209 - 209
  • [46] Outcomes of liver transplant recipients with hepatitis C receiving interferon/ribavirin treatments in an outpatient transplant clinic.
    Smallwood, GA
    Davis, L
    Martinez, E
    Stieber, AC
    Heffron, TG
    PHARMACOTHERAPY, 2003, 23 (10): : 1365 - 1366
  • [47] Consensus Interferon for Recurrent Hepatitis C Infection in Nonresponders to Peginterferon and Ribavirin After Liver Transplant
    Nordstrom, Eric M.
    Biggins, Scott W.
    Gralla, Jane
    Rosen, Hugo R.
    Everson, Gregory T.
    Burton, James R., Jr.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 (06) : 543 - 549
  • [48] Pegylated-interferon for recurrent hepatitis C in liver transplant recipients with renal failure
    Mukherjee, S
    Gilroy, RK
    McCashland, TM
    Schafer, DF
    Zetterman, RK
    Sorrell, MF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S95 - S95
  • [49] SUCCESSFUL TREATMENT OF RENAL TRANSPLANT RECIPIENTS INFECTED WITH CHRONIC HEPATITIS C GENOTYPE 2 WITH PEG-INTERFERON AND RIBAVIRIN COMBINATION THERAPY
    Fujiwara, Kei
    Goto, Norihiko
    Tanaka, Yasuhito
    Hayashi, Katsumi
    Yamada, Tomonori
    Ban, Tesshin
    Kanie, Hiroshi
    Watarai, Yoshihiko
    Uchida, Kazuharu
    Joh, Takashi
    Allison, Robert D.
    Orito, Etsuro
    HEPATOLOGY, 2011, 54 : 839A - 839A
  • [50] Pegylated interferon α-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C
    Ross, AS
    Bhan, AK
    Pascual, M
    Thiim, M
    Cosimi, AB
    Chung, RT
    CLINICAL TRANSPLANTATION, 2004, 18 (02) : 166 - 173
12345